Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Previously submitted to: JMIR mHealth and uHealth (no longer under consideration since Apr 08, 2020)

Date Submitted: Oct 27, 2019
Open Peer Review Period: Oct 24, 2019 - Nov 1, 2019
(closed for review but you can still tweet)

NOTE: This is an unreviewed Preprint

Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).

Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.

Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.

Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.

Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Mobile Health Applications, Cancer Survivors and Lifestyle Modification: An Integrative Review

  • Marjorie M. Kelley; 
  • Jennifer Kue; 
  • Lynne Brophy; 
  • Andrea L. Peabody; 
  • Randi E. Foraker; 
  • Po-Yin Yen; 
  • Sharon Tucker

ABSTRACT

Background:

In 2016, there were 15.5 million cancer survivors in the United States. Survivors’ mortality and well-being are threatened by the risk of cancer recurrence and the prevalence of chronic diseases resulting from cancer treatments. Improving lifestyle behaviors attenuates these risks. Traditional approaches to lifestyle modification (i.e., counseling), are expensive, require significant human resources, and are difficult to scale. Mobile health (mHealth) interventions offer a novel alternative to traditional approaches. Although mHealth interventions are a relatively new phenomenon (c. 2010), their presence and use have increased exponentially in the last few years. However, to date, systematic reviews have failed to examine the use of mHealth interventions in lifestyle behavior change among cancer survivors.

Objective:

: The specific objectives of this integrative review were to (1) identify and synthesize the research in the use of mHealth apps for lifestyle behavior modification among cancer survivors; (2) critically appraise the scientific literature; (3) examine the use of theory in mHealth app design, development and testing; and (4) identify cancer survivors’ preferences in using mHealth apps for lifestyle behavior change.

Methods:

The review process was guided by Whittemore and Knafl’s framework and the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guidelines. We searched 8 databases and 3 journals for studies reported between January 1, 2007, and April 15, 2019, using concepts associated with mobile health, cancer, and lifestyle behaviors. The inclusion of studies and study quality were assessed by at least two research team members, using pre-established criteria and validated tools. We assessed theory use with a coding scheme developed by Michie and Prestwich.

Results:

Of the 1,351 manuscripts retrieved, 19 articles (17 studies) met eligibility requirements. Ten articles reported on the use of mHealth interventions while 9 described mHealth features and functions important to survivors. No RCTs were identified and only 2 quasi-experimental studies were included. Breast cancer survivors were over-represented in the studies as was the lifestyle behavior of physical activity (PA) (n=15). The 2 non-PA studies included in this review focused on stress. Survivors’ perceptions about using mHealth were synthesized into 6 common themes: App Functionality & Features, Social Relationships & Support, Provider Relationships, Support & Communications, Content, Acceptability, and Barriers to Use. The overall quality of the studies was low, except for 3 pilot studies (2 moderate, 1 strong). Only 1 study reported the use of theory in the design, development, or testing of the mHealth intervention.

Conclusions:

Overall, the low-quality of studies included in this review validated a need for rigorous, theory-based pilot and efficacy studies before use of mHealth interventions can be safely and effectively recommended and used to improve lifestyle behaviors in cancer survivors.


 Citation

Please cite as:

Kelley MM, Kue J, Brophy L, Peabody AL, Foraker RE, Yen PY, Tucker S

Mobile Health Applications, Cancer Survivors and Lifestyle Modification: An Integrative Review

JMIR Preprints. 27/10/2019:16784

DOI: 10.2196/preprints.16784

URL: https://preprints.jmir.org/preprint/16784

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.